Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Bausch + Lomb Amends CEO Separation Agreement PR Newswire VAUGHAN, ON, Dec. 22, 2022 VAUGHAN, ON, Dec. 22...
Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating...
Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Win Gold for Most Environmentally Friendly...
Bausch + Lomb's Biotrue® Hydration Plus Multi-Purpose Solution Receives Product of the Year Award from...
Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected...
Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference PR...
Bausch + Lomb Announces Third-Quarter 2022 Results PR Newswire VAUGHAN, ON, Nov. 2, 2022 Third-Quarter 2022...
Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External...
Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs PR Newswire VAUGHAN, ON, Oct. 24, 2022...
Bausch + Lomb Announces Presentation of Scientific Data and Analyses Evaluating Biotrue® Hydration Plus...
Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2 PR Newswire VAUGHAN, ON, Oct. 4...
Bausch + Lomb Introduces Enhanced Ocuvite® Adult 50+ Eye Vitamin Formulation With Vitamin D PR...
Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress PR Newswire VAUGHAN, ON...
Bausch + Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology...
Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings PR Newswire VAUGHAN...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지